Label-free Evaluation of Hepatic Microvesicular Steatosis with Multimodal Coherent Anti-Stokes Raman Scattering Microscopy

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Le, Thuc T ^a,b   Ziemba, Amy ^b   Urasaki, Yasuyo ^a,b   Brotman, Steven ^b   Pizzorno, Giuseppe ^a,b  

^a DESERT RESEARCH INSTITUTE   (United States)

^b NEVADA CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; FAT DROPLET; LIPID; MITOCHONDRIAL TOXIN; OIL RED O; TOXIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID COMPOSITION; LIPID LIVER LEVEL; LIVER CELL; LIVER MICROVESICULAR STEATOSIS; LIVER PARENCHYMA; MICROSCOPY; MOUSE; MULTIMODAL COHERENT ANTI STOKES RAMAN SCATTERING MICROSCOPY; NONHUMAN; SENSITIVITY ANALYSIS; WILD TYPE;

ANIMALS; AZO COMPOUNDS; CELLS, CULTURED; FATTY LIVER; HEPATOCYTES; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICROSCOPY; MICROVESSELS; MITOCHONDRIA; SPECTRUM ANALYSIS, RAMAN; STAINING AND LABELING;

EID: 84870602883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051092     Document Type: Article

References (78)

1. Angulo P, (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
2. Cohen JC, Horton JD, Hobbs HH, (2011) Human fatty liver disease: old questions and new insights. Science 332: 1519-1523.
3. Day CP, James OF, (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
4. Fabbrini E, Sullivan S, Klein S, (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
5. Reddy JK, Rao MS, (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-858.
6. Browning JD, Horton JD, (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152.
7. Lavine JE, Schwimmer JB (2004) Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 8: 549-558, viii-ix.
8. Wang Y, Beydoun MA, (2007) The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29: 6-28.
9. Schneider EL, Guralnik JM, (1990) The aging of America. Impact on health care costs. JAMA 263: 2335-2340.
10. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131.
11. Lee WM, (2003) Drug-induced hepatotoxicity. N Engl J Med 349: 474-485.
12. Navarro VJ, Senior JR, (2006) Drug-related hepatotoxicity. N Engl J Med 354: 731-739.
13. Hoyumpa AM Jr, Greene HL, Dunn GD, Schenker S, (1975) Fatty liver: biochemical and clinical considerations. Am J Dig Dis 20: 1142-1170.
14. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
15. Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM, (2007) Steatosis as a risk factor in liver surgery. Ann Surg 245: 20-30.
16. Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, et al. (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22: 837-844.
17. Diehl AM, Goodman Z, Ishak KG, (1988) Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95: 1056-1062.
18. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, et al. (1993) Frozen section evaluation of donor livers before transplantation. Transplantation 56: 1403-1409.
19. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, et al. (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250: 691-697.
20. Wu YM, Chen HC, Chang WT, Jhan JW, Lin HL, et al. (2009) Quantitative assessment of hepatic fat of intact liver tissues with coherent anti-stokes Raman scattering microscopy. Anal Chem 81: 1496-1504.
21. Brackmann C, Gabrielsson B, Svedberg F, Holmaang A, Sandberg AS, et al. (2010) Nonlinear microscopy of lipid storage and fibrosis in muscle and liver tissues of mice fed high-fat diets. J Biomed Opt 15: 066008.
22. Lin J, Lu F, Zheng W, Xu S, Tai D, et al. (2011) Assessment of liver steatosis and fibrosis in rats using integrated coherent anti-Stokes Raman scattering and multiphoton imaging technique. J Biomed Opt 16: 116024.
23. Cheng JX, Xie XS, (2004) Coherent anti-Stokes Raman scattering microscopy: Instrumentation, theory, and applications. J PhysChem B 108: 827-840.
24. Evans CL, Xie XS, (2008) Coherent Anti-Stokes Raman Scattering Microscopy: Chemically Selective Imaging for Biology and Medicine. Annu Rev Anal Chem 1: 883-909.
25. Krafft C, Dietzek B, Schmitt M, Popp J, (2012) Raman and coherent anti-Stokes Raman scattering microspectroscopy for biomedical applications. J Biomed Opt 17: 040801.
26. Le TT, Yue S, Cheng JX, (2010) Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy. J Lipid Res 51: 3091-3102.
27. Klotzsch SG, McNamara JR, (1990) Triglyceride measurements: a review of methods and interferences. Clin Chem 36: 1605-1613.
28. Hellerer T, Axang C, Brackmann C, Hillertz P, Pilon M, et al. (2007) Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc Natl Acad Sci U S A 104: 14658-14663.
29. Le TT, Duren HM, Slipchenko MN, Hu CD, Cheng JX, (2010) Label-free quantitative analysis of lipid metabolism in living Caenorhabditis elegans. J Lipid Res 51: 672-677.
30. Yen K, Le TT, Bansal A, Narasimhan SD, Cheng JX, et al. (2010) A comparative study of fat storage quantitation in nematode Caenorhabditis elegans using label and label-free methods. PLoS One 5: e12810.
31. Slipchenko MN, Le TT, Chen H, Cheng JX, (2009) High-speed vibrational imaging and spectral analysis of lipid bodies by compound Raman microscopy. J Phys Chem B 113: 7681-7686.
32. Rinia HA, Burger KNJ, Bonn M, Muller M, (2008) Quantitative Label-Free Imaging of Lipid Composition and Packing of Individual Cellular Lipid Droplets Using Multiplex CARS Microscopy. Biophys J 95: 4908-4914.
33. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, et al. (2007) Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110: 4077-4085.
34. Crofton RW, Diesselhoff-den Dulk MM, van Furth R, (1978) The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med 148: 1-17.
35. Roth B, Fkelund M, Fan BG, Hagerstrand I, Nilsson-Ehle P, (1996) Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: a biochemical and ultrastructural study. Intensive Care Med 22: 1224-1231.
36. Tong L, He W, Zhang Y, Zheng W, Cheng JX, (2009) Visualizing systemic clearance and cellular level biodistribution of gold nanorods by intrinsic two-photon luminescence. Langmuir 25: 12454-12459.
37. Le TT, Langohr IM, Locker MJ, Sturek M, Cheng JX, (2007) Label-free molecular imaging of atherosclerotic lesions using multimodal nonlinear optical microscopy. J Biomed Opt 12: 054007.
38. Urasaki Y, Johlfs MG, Fiscus RR, Le TT, (2012) Imaging immune and metabolic cells of visceral adipose tissues with multimodal nonlinear optical microscopy. PLoS One 7: e38418.
39. Knowles RG, Moncada S, (1994) Nitric oxide synthases in mammals. Biochem J 298 (Pt 2): 249-258.
40. Dutta PK, Nestor JR, Spiro TG, (1977) Resonance coherent anti-Stokes Raman scattering spectra of fluorescent biological chromophores: Vibrational evidence for hydrogen bonding of flavin to glucose oxidase and for rapid solvent exchange. Proc Natl Acad Sci U S A 74: 4146-4149.
41. Visser AJ, Vervoort J, O'Kane DJ, Lee J, Carreira LA, (1983) Raman spectra of flavin bound in flavodoxins and in other flavoproteins. Evidence for structural variations in the flavin-binding region. Eur J Biochem 131: 639-645.
42. Lang J, Driscoll D, Gelinas S, Rafferty SP, Couture M, (2009) Trp180 of endothelial NOS and Trp56 of bacterial saNOS modulate sigma bonding of the axial cysteine to the heme. J Inorg Biochem 103: 1102-1112.
43. Lim RS, Suhalim JL, Miyazaki-Anzai S, Miyazaki M, Levi M, et al. (2011) Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res 52: 2177-2186.
44. Pezacki JP, Blake JA, Danielson DC, Kennedy DC, Lyn RK, et al. (2011) Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy. Nat Chem Biol 7: 137-145.
45. Seglen PO, (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13: 29-83.
46. Bissell DM, Guzelian PS, (1980) Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Ann N Y Acad Sci 349: 85-98.
47. LeCluyse EL, (2001) Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13: 343-368.
48. Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B, (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54: 773-794.
49. Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH, (2001) Drug-induced liver injury: mechanisms and test systems. Hepatology 33: 1009-1013.
50. Helmchen F, Denk W, (2005) Deep tissue two-photon microscopy. Nat Methods 2: 932-940.
51. Segawa H, Okuno M, Kano H, Leproux P, Couderc V, et al. (2012) Label-free tetra-modal molecular imaging of living cells with CARS, SHG, THG and TSFG. Opt Express 20: 9551-9557.
52. Zhu J, Lee B, Buhman KK, Cheng JX, (2009) A dynamic cytoplasmic triacylglycerol pool in enterocytes revealed by ex vivo and in vivo coherent anti-Stokes Raman scattering imaging. J Lipid Res 50: 1080-1089.
53. Huff TB, Cheng JX, (2007) In vivo coherent anti-Stokes Raman scattering imaging of sciatic nerve tissue. J Microscopy-Oxford 225: 175-182.
54. Fu Y, Huff TB, Wang HW, Wang HF, Cheng JX, (2008) Ex vivo and in vivo imaging of myelin fibers in mouse brain by coherent anti-Stokes Raman microscopy. Opt Express 16: 19396-19409.
55. Belanger E, Crepeau J, Laffray S, Vallee R, De Koninck Y, et al. (2012) Live animal myelin histomorphometry of the spinal cord with video-rate multimodal nonlinear microendoscopy. J Biomed Opt 17: 021107.
56. Wang HF, Fu Y, Zickmund P, Shi RY, Cheng JX, (2005) Coherent anti-stokes Raman scattering imaging of axonal myelin in live spinal tissues. Biophys J 89: 581-591.
57. Nan XL, Cheng JX, Xie XS, (2003) Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy. J Lipid Res 44: 2202-2208.
58. Nan XL, Potma EO, Xie XS, (2006) Nonperturbative chemical imaging of organelle transport in living cells with coherent anti-stokes Raman scattering microscopy. Biophys J 91: 728-735.
59. Yamaguchi T, Omatsu N, Morimoto E, Nakashima H, Ueno K, et al. (2007) CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J Lipid Res 48: 1078-1089.
60. Le TT, Cheng JX, (2009) Single-cell profiling reveals the origin of phenotypic variability in adipogenesis. PLoS ONE 4: e5189.
61. Paar M, Jungst C, Steiner NA, Magnes C, Sinner F, et al. (2012) Remodeling Of lipid droplets during lipolysis and growth in adipocytes. J Biol Chem 287: 11164-11173.
62. Lyn RK, Kennedy DC, Sagan SM, Blais DR, Rouleau Y, et al. (2009) Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism. Virology 394: 130-142.
63. Kim SH, Lee ES, Lee JY, Lee BS, Park JE, et al. (2010) Multiplex coherent anti-stokes Raman spectroscopy images intact atheromatous lesions and concomitantly identifies distinct chemical profiles of atherosclerotic lipids. Circ Res 106: 1332-1341.
64. Ko AC, Ridsdale A, Smith MS, Mostaco-Guidolin LB, Hewko MD, et al. (2010) Multimodal nonlinear optical imaging of atherosclerotic plaque development in myocardial infarction-prone rabbits. J Biomed Opt 15: 020501.
65. Imitola J, Cote D, Rasmussen S, Xie XS, Liu Y, et al. (2011) Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice. J Biomed Opt 16: 021109.
66. Li L, Wang H, Cheng JX, (2005) Quantitative coherent anti-Stokes Raman scattering imaging of lipid distribution in coexisting domains. Biophys J 89: 3480-3490.
67. Min W, Freudiger CW, Lu S, Xie XS, (2011) Coherent nonlinear optical imaging: beyond fluorescence microscopy. Annu Rev Phys Chem 62: 507-530.
68. Meyer T, Bergner N, Medyukhina A, Dietzek B, Krafft C, et al. (2012) Interpreting CARS images of tissue within the C-H-stretching region. J Biophotonics 5: 729-733.
69. Medyukhina A, Meyer T, Schmitt M, Romeike BF, Dietzek B, et al. (2012) Towards automated segmentation of cells and cell nuclei in nonlinear optical microscopy. J Biophotonics.
70. Zhai YH, Goulart C, Sharping JE, Wei H, Chen S, et al. (2011) Multimodal coherent anti-Stokes Raman spectroscopic imaging with a fiber optical parametric oscillator. Appl Phys Lett 98: 191106.
71. Pegoraro AF, Ridsdale A, Moffatt DJ, Pezacki JP, Thomas BK, et al. (2009) All-fiber CARS microscopy of live cells. Opt Express 17: 20700-20706.
72. Kieu K, Saar BG, Holtom GR, Xie XS, Wise FW, (2009) High-power picosecond fiber source for coherent Raman microscopy. Opt Lett 34: 2051-2053.
73. Gottschall T, Baumgartl M, Sagnier A, Rothhardt J, Jauregui C, et al. (2012) Fiber-based source for multiplex-CARS microscopy based on degenerate four-wave mixing. Opt Express 20: 12004-12013.
74. Evans CL, Xu XY, Kesari S, Xie XS, Wong STC, et al. (2007) Chemically-selective imaging of brain structures with CARS microscopy. Opt Express 15: 12076-12087.
75. Wang HW, Langohr IM, Sturek M, Cheng JX, (2009) Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy. Arterioscler Thromb Vasc Biol 29: 1342-1348.
76. Brunmair B, Lest A, Staniek K, Gras F, Scharf N, et al. (2004) Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther. 311: 109-114.
77. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, et al. (2009) Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 37: 521-535.
78. Balfour JA, McTavish D, Heel RC, (1990) Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs 40: 260-290.